Cite
Induction and characterization of anti-tumor endothelium immunity elicited by ValloVax therapeutic cancer vaccine.
MLA
Wagner, Samuel C., et al. “Induction and Characterization of Anti-Tumor Endothelium Immunity Elicited by ValloVax Therapeutic Cancer Vaccine.” Oncotarget, vol. 8, no. 17, Apr. 2017, pp. 28595–613. EBSCOhost, https://doi.org/10.18632/oncotarget.15563.
APA
Wagner, S. C., Ichim, T. E., Bogin, V., Min, W.-P., Silva, F., Patel, A. N., & Kesari, S. (2017). Induction and characterization of anti-tumor endothelium immunity elicited by ValloVax therapeutic cancer vaccine. Oncotarget, 8(17), 28595–28613. https://doi.org/10.18632/oncotarget.15563
Chicago
Wagner, Samuel C, Thomas E Ichim, Vladimir Bogin, Wei-Ping Min, Francisco Silva, Amit N Patel, and Santosh Kesari. 2017. “Induction and Characterization of Anti-Tumor Endothelium Immunity Elicited by ValloVax Therapeutic Cancer Vaccine.” Oncotarget 8 (17): 28595–613. doi:10.18632/oncotarget.15563.